:: Welcome to CHARAK ::

About UsAyurvedaProductsClinicSymptomsDiseases

Call Dr. Charak
91 022 3003 6646
The Charak Research and Development Center :
PREFORMULATION STANDARDS
Every formulation that goes to the market is extensively studied and sends for Formulation Development. For which we have a Library, Museum and a Documentation collection division. Every plant which goes into formulation are thoroughly screened by obtaining all the chemical and pharmacological data from National and International Journals by using primarily with Ayurvedic Concepts. Selection of crude drugs, selection of Standardised Extracts, Quality Evaluation of Extracts is predetermined.

Every formulation that is taken for development where a separate document is prepared which enable the Marketing Department also to use.

During preformulations decisions number of brain storming sessions are done where entire industry participate.

  • Marketing
  • R&D
  • Ayurvedic Clinicians

Every formulation is a very delicate balance between the old age traditional concepts of Ayurved like Doshas, Panchma habutas and Saptadhatus and the modern scientific concepts of infection, antioxidant and immunity building, your team always aims to draw parallels between the ancient concepts and contemporary thoughts which results into a modern-day formulation which can be easily administered. We at Charak have realized market are to be 'scientific', 'evidence based', 'herbal and also to develop products which can be easily taken like Capsules, Tablets, Syrups and our strong R&D team.

For more details on various projects undertaken and completed by our R&D department mail to askdoctor@charak.com

We undertake formula development work from concept stage to documentation and development stage. Send in your needs to us and we can get back to you.
 
 
 
 
Back
 
     

Home | Ask Dr Charak | Distributors | Sitemap | Contact Us

© 2003-2004 Charak Pharmaceuticals. All Rights Reserved. Disclaimer
Site maintained and updated by Idealake Information Technologies Pvt. Ltd.